Evidence map›Paper›PMID 39473893›Full record

ArticleFrontiers in cardiovascular medicine2024

Case Report: Laboratory detection of a thrombotic tendency in a family with hypodysfibrinogenemia and a novel

Amaury Monard, Elisabetta Castoldi, Ilaria De Simone, Kanin Wichapong, Tirsa van Duijl, Maartje van den Biggelaar, Stefano Spada, William van Doorn, Dave Hellenbrand, Paola van der Meijden and 6 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Amaury MonardDepartment of Internal Medicine-Hematology, Maastricht University Medical Centre+, Maastricht, Netherlands.
Elisabetta CastoldiDepartment of Biochemistry, CARIM, Maastricht University, Maastricht, Netherlands.
Ilaria De SimoneDepartment of Biochemistry, CARIM, Maastricht University, Maastricht, Netherlands.
Kanin WichapongDepartment of Biochemistry, CARIM, Maastricht University, Maastricht, Netherlands.
Tirsa van DuijlDepartment of Molecular Hematology, Sanquin Research, Amsterdam, Netherlands.
Maartje van den BiggelaarDepartment of Molecular Hematology, Sanquin Research, Amsterdam, Netherlands.
Stefano SpadaDepartment of Biochemistry, CARIM, Maastricht University, Maastricht, Netherlands.
William van DoornCentral Diagnostic Laboratory, Maastricht University Medical Centre+, Maastricht, Netherlands.
Dave HellenbrandCentral Diagnostic Laboratory, Maastricht University Medical Centre+, Maastricht, Netherlands.
Paola van der MeijdenCARIM, School for Cardiovascular Disease, Maastricht University, Maastricht, Netherlands.
Frauke SwieringaDepartment of Biochemistry, CARIM, Maastricht University, Maastricht, Netherlands.
Alexander StorkDepartment of Internal Medicine, Anna Hospital, Geldrop, Netherlands.
Hugo Ten CateDepartment of Biochemistry, CARIM, Maastricht University, Maastricht, Netherlands.
Erik BeckersDepartment of Internal Medicine-Hematology, Maastricht University Medical Centre+, Maastricht, Netherlands.
Floor Heubel-Moenen *Department of Internal Medicine-Hematology, Maastricht University Medical Centre+, Maastricht, Netherlands.
Yvonne Henskens *CARIM, School for Cardiovascular Disease, Maastricht University, Maastricht, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hypodysfibrinogenemia is a rare congenital fibrinogen disorder (CFD) which may induce thrombotic and bleeding events. Therefore, patient management needs careful evaluation. Routine coagulation tests are inadequate to predict the clinical phenotype. Clinical findings: A 60-year-old woman with both bleeding and thrombotic complications and her two daughters were referred to our center for genotypic and phenotypic analysis of a CFD. Diagnosis: Conventional laboratory results led to the diagnosis of hypodysfibrinogenemia in all three subjects. They all carried the same heterozygous c.1124A>G mutation in Conclusion: We report on a family with hypodysfibrinogenemia and a novel

Indexed as

case reportcongenital fibrinogen disordersdiagnosishypodysfibrinogenemiaphenotype

Identifiers

PMID39473893
PMCPMC11518780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.